Magnorate Tablet is a pharmaceutical formulation combining Dibasic Calcium Phosphate (136 mg) and Magnesium Orotate (500 mg), designed to support bone health and metabolic functions. Dibasic Calcium Phosphate serves as a bioavailable source of calcium, essential for maintaining structural integrity of bones and teeth, as well as playing a critical role in neuromuscular transmission and vascular contraction. Magnesium Orotate, a highly absorbable form of magnesium bound to orotic acid, contributes to numerous physiological processes including enzymatic reactions, energy production, and regulation of muscle and nerve function. The synergistic action of calcium and magnesium in Magnorate Tablet aids in the prevention and management of mineral deficiencies, which may arise due to inadequate dietary intake, malabsorption, or increased physiological demand. This combination is particularly beneficial in conditions such as osteoporosis, hypocalcemia, and magnesium deficiency, promoting optimal bone mineralization and reducing the risk of fractures. Additionally, magnesium orotate has been studied for its potential cardioprotective effects by improving myocardial energy metabolism. Magnorate Tablet should be administered under medical supervision, with dosage tailored according to individual patient needs and clinical condition. Contraindications include hypercalcemia, hypermagnesemia, and known hypersensitivity to any component of the formulation.